ConductScience.org, home

Paper30596166

Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol.

Tucker BM and 1 other. Kidney Int Rep, 2019. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol. Papers, record 30596166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30596166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol.
PubMed
Journal
Kidney Int Rep
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2020-10-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tucker BMBryan M
2Perazella MAMark A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110492419Does use of propofol in heavy alcohol drinkers tend to discolor their urine?Acta Anaesthesiol Scand1999https://conductscience.org/library/papers/10492419PubMed
211298778Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes.Eur J Clin Invest2001https://conductscience.org/library/papers/11298778PubMed
311572907Boy with 'rainbow' urine.Nephrol Dial Transplant2001https://conductscience.org/library/papers/11572907PubMed
41175621Isolation and identification of the urinary pigment uroerythrin.Eur J Biochem1975https://conductscience.org/library/papers/1175621PubMed
511982475Antidiuretic hormone release during laparoscopic donor nephrectomy.Arch Surg2002https://conductscience.org/library/papers/11982475PubMed
612160192Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent.Am J Hypertens2002https://conductscience.org/library/papers/12160192PubMed
712941774
Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism.
Diabetes2003https://conductscience.org/library/papers/12941774PubMed
81319189The antioxidant potential of propofol (2,6-diisopropylphenol).Br J Anaesth1992https://conductscience.org/library/papers/1319189PubMed
913237Isolation and characterization of uricine from uric acid stones.Kidney Int1976https://conductscience.org/library/papers/13237PubMed
1013930523Interrelation of uric acid and ethanol metabolism in man.J Clin Invest1962https://conductscience.org/library/papers/13930523PubMed
1114717908The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.Kidney Int2004https://conductscience.org/library/papers/14717908PubMed
1215086484Association of urinary pH with body weight in nephrolithiasis.Kidney Int2004https://conductscience.org/library/papers/15086484PubMed
1315252178Apricot urine in autumn.Nephrol Dial Transplant2004https://conductscience.org/library/papers/15252178PubMed
1415579060Propofol: therapeutic indications and side-effects.Curr Pharm Des2004https://conductscience.org/library/papers/15579060PubMed
1515604613Uric acid elimination in the urine. Pathophysiological implications.Contrib Nephrol2005https://conductscience.org/library/papers/15604613PubMed
1616192780Propofol: the challenges of formulation.Anesthesiology2005https://conductscience.org/library/papers/16192780PubMed
1716458The effect of urine flow rate on urate clearance.Adv Exp Med Biol1977https://conductscience.org/library/papers/16458PubMed
1816474948Influence of body size on urinary stone composition in men and women.Urol Res2006https://conductscience.org/library/papers/16474948PubMed
1916597681Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.J Am Soc Nephrol2006https://conductscience.org/library/papers/16597681PubMed
2117018843Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin.Am J Physiol Renal Physiol2007https://conductscience.org/library/papers/17018843PubMed

See all 94 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41030368Pink Urine Syndrome: A Rare Propofol-Associated Phenomenon in Critically Ill Patients.Case Rep Crit Care2025https://conductscience.org/library/papers/41030368PubMed
37346301Editorial: Case reports in neuropharmacology 2022.Front Pharmacol2023https://conductscience.org/library/papers/37346301PubMed
34211398Case Report: Pink Urine Syndrome Following Exposure to Propofol: A Rare, Impressive but Benign Complication.Front Pharmacol2021https://conductscience.org/library/papers/34211398PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30596166

GET https://conductscience.org/api/papers/v1/30596166/references?page=2